Cargando…

The Intrinsic and Extrinsic Implications of RANKL/RANK Signaling in Osteosarcoma: From Tumor Initiation to Lung Metastases

Background: Osteosarcoma is the most frequent form of malignant pediatric bone tumor. Despite the current therapeutic arsenal, patient life-expectancy remains low if metastases are detected at the time of diagnosis, justifying research into better knowledge at all stages of osteosarcoma ontogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navet, Benjamin, Ando, Kosei, Vargas-Franco, Jorge William, Brion, Régis, Amiaud, Jérome, Mori, Kanji, Yagita, Hideo, Mueller, Christopher G., Verrecchia, Franck, Dumars, Clotilde, Heymann, Marie-Françoise, Heymann, Dominique, Lézot, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265790/ https://www.ncbi.nlm.nih.gov/pubmed/30355966 http://dx.doi.org/10.3390/cancers10110398

Ejemplares similares

RANK–RANKL signalling in cancer
por: Renema, Nathalie, et al.
Publicado: (2016)

Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups
por: Navet, Benjamin, et al.
Publicado: (2018)

Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases
por: Lamora, Audrey, et al.
Publicado: (2015)

Molecular Alterations Associated with Osteosarcoma Development
por: Ando, Kosei, et al.
Publicado: (2012)

Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma
por: Muñoz-Garcia, Javier, et al.
Publicado: (2022)

ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells
por: Danieau, Geoffroy, et al.
Publicado: (2021)

LIM Kinases in Osteosarcoma Development
por: Brion, Régis, et al.
Publicado: (2021)

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
por: Ando, Kosei, et al.
Publicado: (2013)

Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma
por: Dumars, Clotilde, et al.
Publicado: (2016)

Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
por: Picarda, Gaëlle, et al.
Publicado: (2013)

Advances in Osteosarcoma
por: Panez-Toro, Isidora, et al.
Publicado: (2023)

Jaw osteosarcoma models in mice: first description
por: Bertin, Hélios, et al.
Publicado: (2019)

Primary Retention of Molars and RANKL Signaling Alteration during Craniofacial Growth
por: Gama, Andrea, et al.
Publicado: (2020)

Origins of Alterations to Rankl Null Mutant Mouse Dental Root Development
por: Gama, Andrea, et al.
Publicado: (2020)

The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis
por: Muñoz-Garcia, Javier, et al.
Publicado: (2021)

RANK/RANKL/OPG Signalization Implication in Periodontitis: New Evidence from a RANK Transgenic Mouse Model
por: Sojod, Bouchra, et al.
Publicado: (2017)

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619
por: Lavaud, Mélanie, et al.
Publicado: (2021)

Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
por: Gobin, Bérengère, et al.
Publicado: (2014)

Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing’s Sarcoma Tumor Growth
por: Mullard, Mathilde, et al.
Publicado: (2020)

Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences
por: Heymann, Dominique
Publicado: (2012)

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence
por: Perrot, Pierre, et al.
Publicado: (2010)

Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients
por: Heymann, Clément J.F., et al.
Publicado: (2022)

SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression
por: Lézot, Frédéric, et al.
Publicado: (2020)

Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis
por: Morice, Sarah, et al.
Publicado: (2021)

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth
por: Morice, Sarah, et al.
Publicado: (2020)

Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma
por: Jubelin, Camille, et al.
Publicado: (2022)

RANK/RANKL expression in prostate cancer
por: Ohtaka, Mari, et al.
Publicado: (2016)

The Roadmap of RANKL/RANK Pathway in Cancer
por: Casimiro, Sandra, et al.
Publicado: (2021)

Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy
por: Dufresne, Sébastien S., et al.
Publicado: (2018)

Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment
por: Verrecchia, Franck, et al.
Publicado: (2018)

Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy
por: Chalopin, Antoine, et al.
Publicado: (2018)

Hemophilia A and B mice, but not VWF(−/−)mice, display bone defects in congenital development and remodeling after injury
por: Taves, Sarah, et al.
Publicado: (2019)

RANK, RANKL and osteoprotegerin in bone biology and disease
por: Wright, H. L., et al.
Publicado: (2009)

RANK/RANKL/OPG system in the intervertebral disc
por: Takegami, Norihiko, et al.
Publicado: (2017)

The Osteosarcoma Microenvironment: A Complex but Targetable Ecosystem
por: Corre, Isabelle, et al.
Publicado: (2020)

Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis
por: Lleo, Ana, et al.
Publicado: (2016)

Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
por: Ming, Jie, et al.
Publicado: (2020)

The Role of the RANKL/RANK Axis in the Prevention and Treatment of Breast Cancer with Immune Checkpoint Inhibitors and Anti-RANKL
por: Simatou, Aristofania, et al.
Publicado: (2020)

Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements
por: Jubelin, Camille, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u4imbufffscbjdk4rtsoktl55u